The ROE as of September 2024 (TTM) for Sana Biotechnology, Inc. (SANA) is -71.60%

According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is -71.60%. This represents a change of 287.89% compared to the average of -18.46% of the last 4 quarters.

Sana Biotechnology, Inc. (SANA) Historical ROE (quarterly & annually)

How has SANA ROE performed in the past?

The mean historical ROE of Sana Biotechnology, Inc. over the last ten years is 9.87%. The current -71.60% ROE has changed -825.28% with respect to the historical average. Over the past ten years (40 quarters), SANA's ROE was at its highest in in the December 2019 quarter at 30.20%. The ROE was at its lowest in in the June 2023 quarter at -32.11%.

Sana Biotechnology, Inc. (SANA) ROE by Quarter and Year

Discovering the peaks and valleys of Sana Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sana Biotechnology, Inc. (SANA) Average ROE

How has SANA ROE performed in the past?

The current ROE of Sana Biotechnology, Inc. (SANA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sana Biotechnology, Inc. (SANA) ROE vs. Peers

How is SANA’s ROE compared to its peers?

Sana Biotechnology, Inc.’s ROE is greater than Olema Pharmaceuticals, Inc. (-44.18%), greater than Cullinan Oncology, Inc. (-28.37%), greater than aTyr Pharma, Inc. (-56.83%), greater than Zentalis Pharmaceuticals, Inc. (-44.23%), less than X4 Pharmaceuticals, Inc. (32.93%), less than Galera Therapeutics, Inc. (21.95%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than Revolution Medicines, Inc. (-34.57%), greater than Blueprint Medicines Corporation (-85.25%), greater than Kymera Therapeutics, Inc. (-28.88%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Nkarta, Inc. (-28.83%), greater than Lyell Immunopharma, Inc. (-33.35%), greater than Generation Bio Co. (-92.86%), greater than Mirati Therapeutics, Inc. (-81.10%), greater than Amylyx Pharmaceuticals, Inc. (-46.15%), greater than Apellis Pharmaceuticals, Inc. (-139.02%),

Build a custom stock screener for Sana Biotechnology, Inc. (SANA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sana Biotechnology, Inc. (SANA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.